CN102512650A - Externally-used medicine for treating facial paralysis - Google Patents

Externally-used medicine for treating facial paralysis Download PDF

Info

Publication number
CN102512650A
CN102512650A CN2011104544044A CN201110454404A CN102512650A CN 102512650 A CN102512650 A CN 102512650A CN 2011104544044 A CN2011104544044 A CN 2011104544044A CN 201110454404 A CN201110454404 A CN 201110454404A CN 102512650 A CN102512650 A CN 102512650A
Authority
CN
China
Prior art keywords
facial paralysis
used medicine
medicine
externally
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2011104544044A
Other languages
Chinese (zh)
Inventor
马海军
王六贵
吕建英
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanxi Zhendong Kaiyuan Pharmaceutical Co Ltd
Original Assignee
Shanxi Zhendong Kaiyuan Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanxi Zhendong Kaiyuan Pharmaceutical Co Ltd filed Critical Shanxi Zhendong Kaiyuan Pharmaceutical Co Ltd
Priority to CN2011104544044A priority Critical patent/CN102512650A/en
Publication of CN102512650A publication Critical patent/CN102512650A/en
Pending legal-status Critical Current

Links

Abstract

An externally-used medicine for treating facial paralysis is prepared into a powder product by uniformly mixing prepared monkshood, prepared monkshood, prepared frankincense and ginger which are carefully selected and washed cleanly by clear water, grinding the mixture into 100-120 medicinal powder, sterilizing and disinfecting the medicinal powder. The externally-used medicine for treating the facial paralysis has effects of expelling wind, dredging main and collateral channels, warming menses and expelling cold, and has good effect of treating the facial paralysis, without toxic or side effects.

Description

The prosopoplegic external used medicine of a kind of treatment
Technical field
The present invention relates to the prosopoplegic external used medicine of a kind of treatment, especially relating to a kind of is the prosopoplegic external used medicine of treatment of crude drug preparation with Chinese medicine.
Background technology
Facial paralysis is commonly called as " facial paralysis ", " wapperijaw crust ", " wapperijaw ", " facial paralysis " is to be a kind of commonly encountered diseases of principal character with facial expression muscle group dyskinesia; General symptom be facial hemiparalysis it be a kind of commonly encountered diseases, frequently-occurring disease, it does not receive age limit.Actions such as patient's face is often the most basic lifts eyebrow, close one's eyes, drum mouth all can't be accomplished, and can leave over sequela in various degree like malpractice, have a strong impact on people's image.
At present, the facial paralysis doctor trained in Western medicine is mainly treated through the Western medicine that uses dehydration, detumescence, trophic nerve, but less patient suffering is big, expense is high; The traditional Chinese medical science is mainly treated through acupuncture and oral Chinese medicine, still takes effect slowly, treats loaded down with trivial details; Or use some modern physiotherapy equipment to treat, but relative costs is high, effect is undesirable.
Summary of the invention
The purpose of this invention is to provide a kind of is the prosopoplegic external used medicine of treatment of crude drug preparation with Chinese medicine, and this medicine is with dispelling wind and removing obstruction in the collateral, and dispelling cold by warming the meridian is the principle treatment, and therapeutic effect is good, and expense is low.
Medicine of the present invention is that crude drug prepares by following parts by weight of traditional Chinese medicines:
Radix Aconiti Lateralis Preparata 8~10 Radix Aconiti Preparatas 8~10 Olibanum (processed)s 5~7 Rhizoma Zingiberis Recenss 2~4.
The medicine of above-mentioned each component can be processed said exterior-applied formulation on any pharmaceuticss such as unguentum, liniment, powder, and the preferred dosage form of the present invention is a powder.
The concrete method for preparing of drug powder of the present invention is: said medicine by said parts by weight mix homogeneously, is ground into 100~120 purpose medicated powder, and sterilization makes the powder product.
The method for using of powder of the present invention: powder is with boiled water furnishing pasty state, and the drug application Ipsilateral is the center with external auditory meatus, and each 3 centimeters up and down, wide 3 centimeters strip.
In the prescription of the present invention, the Radix Aconiti Lateralis Preparata dispersing cold for relieving pain; The Radix Aconiti Preparata expelling wind and removing dampness, antalgic; The Olibanum (processed) promoting blood circulation and stopping pain; The Rhizoma Zingiberis Recens cold expelling that induces sweat, warming middle-JIAO to arrest vomiting.All medicines share, and can play dispelling wind and removing obstruction in the collateral, and the effect of dispelling cold by warming the meridian is evident in efficacy to the treatment facial paralysis, and cheap.
For further investigating the prosopoplegic clinical efficacy of Drug therapy of the present invention, select 63 routine facial paralysis patients to carry out clinical observation on the therapeutic effect.
Be divided into treatment group and matched group to 63 routine patients, 30 people are organized in treatment, matched group 33 people.
All case is all according to the main diagnosis basis in " practical combination of Chinese and Western medicine neurological ":
1, onset is unexpected;
2, the Ipsilateral palpebral fissure is big, and eyelid can not be closed, sheds tears; The volume stricture of vagina disappears, and can not frown;
3, the Ipsilateral nasolabial fold shoals or is smooth, and bicker is low and to strong side-lining.
Be diagnosed as facial paralysis.
Therapeutic Method
Matched group adopts 250 milliliters of mannitol injections, 10 milligrams of dexamethasone, and quiet of every day 1 time, a week is a course of treatment;
The treatment group adopts powder agent medicine of the present invention, and external every day is smeared 1 time, and a week is a course of treatment.
Before and after the treatment, treatment group and matched group facial paralysis patient laboratory data are seen table 1:
The variation of each parameter before and after the table 1 facial paralysis patient treatment
Figure 2011104544044100002DEST_PATH_IMAGE001
Criterion of therapeutical effect
Criterion of therapeutical effect with reference to " clinical disease diagnosis is according to curing the improvement standard ".Cure: the symptom complete obiteration, catacleisis is good, the area functional rehabilitation.Effectively: the volume stricture of vagina recovers, up and down a little less than the catacleisis strength, and the visible slight ptosis of labial angle of Ipsilateral when laughing at of crying, facial muscle group contractile motion is poor slightly.Invalid: symptom does not have obvious change.
Two groups of case treatment back curative effect comparative results are seen table 2.
Table 2 liang group case treatment back curative effect relatively.
Group The example number Cure n (%) Effective n (%) Invalid n (%) Total effective rate n (%)
Matched group 33 11(33.3) 14(42.5) ?8(24.2) 25(75.8)
The treatment group 30 13(43.3) 14(46.7) 3(10) 27(90)
The specific embodiment
Embodiment 1
Get Radix Aconiti Lateralis Preparata 80g, Radix Aconiti Preparata 80g, Olibanum (processed) 50g, Rhizoma Zingiberis Recens 20g mix homogeneously selected, that clear water is cleaned, be ground into 100~120 medicated powder, sterilization makes the powder product.
Embodiment 2
Get Radix Aconiti Lateralis Preparata 100g, Radix Aconiti Preparata 100g, Olibanum (processed) 70g, Rhizoma Zingiberis Recens 40g, mix homogeneously selected, that clear water is cleaned, be ground into 100~120 medicated powder, sterilization adds adjuvant by conventional method, makes the unguentum product.

Claims (2)

1. prosopoplegic external used medicine of treatment is that crude drug prepares by the Chinese medicine of following portions by weight:
Radix Aconiti Lateralis Preparata 8~10 Radix Aconiti Preparatas 8~10 Olibanum (processed)s 5~7 Rhizoma Zingiberis Recenss 2~4.
2. the prosopoplegic external used medicine of treatment according to claim 1 is characterized in that said medicine is processed powder.
CN2011104544044A 2011-12-30 2011-12-30 Externally-used medicine for treating facial paralysis Pending CN102512650A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011104544044A CN102512650A (en) 2011-12-30 2011-12-30 Externally-used medicine for treating facial paralysis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011104544044A CN102512650A (en) 2011-12-30 2011-12-30 Externally-used medicine for treating facial paralysis

Publications (1)

Publication Number Publication Date
CN102512650A true CN102512650A (en) 2012-06-27

Family

ID=46283902

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011104544044A Pending CN102512650A (en) 2011-12-30 2011-12-30 Externally-used medicine for treating facial paralysis

Country Status (1)

Country Link
CN (1) CN102512650A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103127259A (en) * 2013-02-20 2013-06-05 张媛媛 Chinese medicine capable of curing facial neural paralysis and preparation method thereof
CN111067948A (en) * 2020-01-15 2020-04-28 林红 Traditional Chinese medicine composition for treating facial paralysis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
阮沸翔: "《百岁良方-药茶药酒及其它独特疗法》", 30 November 1993, 湖南出版社 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103127259A (en) * 2013-02-20 2013-06-05 张媛媛 Chinese medicine capable of curing facial neural paralysis and preparation method thereof
CN103127259B (en) * 2013-02-20 2015-01-07 王秀杰 Chinese medicine capable of curing facial neural paralysis and preparation method thereof
CN111067948A (en) * 2020-01-15 2020-04-28 林红 Traditional Chinese medicine composition for treating facial paralysis

Similar Documents

Publication Publication Date Title
CN103239520B (en) Moslemic ointment for treating osteoarthritis and preparation method of moslemic ointment
CN102872241A (en) Traditional Chinese medicinal composition for treating inflammatory dermatosis and preparation thereof
CN103394031B (en) Medicament for treating sciatica
CN107050118A (en) It is a kind of to treat Chinese medicine patch of caused by wind, cold and wetness evils and preparation method thereof
CN103977194A (en) Application of drug for external use capable of effectively treating wound infection in preparing medicaments for treating diabetic foot
CN102247501A (en) Medicine for treating soft tissue injury
CN102512650A (en) Externally-used medicine for treating facial paralysis
CN102188758A (en) Preparation method for solid implantation catgut for treating spinal diseases
CN113599498B (en) Composite antibacterial peptide and preparation method thereof, and bee venom conditioning cream capable of quickly relieving pain and preparation method thereof
CN102319330B (en) Traditional Chinese medicine cataplasma for treating hyperosteogeny and preparation method thereof
CN101804179B (en) Traditional Chinese medicine composition for treating hyperosteogeny of cervical vertebra and lumbar vertebra and preparation method thereof
CN104800663A (en) Traditional Chinese medicinal liquor for treating hyperostosis and preparation method of traditional Chinese medicinal liquor
CN109528912A (en) A kind of cupping Chinese medicine composition and preparation method thereof
CN104547222A (en) Traditional Chinese medicine patching agent for treating hyperostosis
CN1723933A (en) Traditional Chinese medicine capsule for treating application, and its prodn. method
CN110269926A (en) Middle benefit gas, which is relaxed, warms up composition and its preparation method and application
CN110123925A (en) It is a kind of to treat hydrocephalic nasal nanometer emulsion in-situ gel and preparation method thereof
CN108404094A (en) A kind of thin network analgesic antiphlogistic bee venom application conditioning cream
CN103623007B (en) A kind of external-applied ointment and preparation and application thereof for the treatment of the ringworm of scalp
CN108743818A (en) External application is dispelled osteoarthropathy medicinal liquor
CN102579617A (en) Traditional Chinese medicine capsule for treating chronic neck, shoulder, waist and leg pains and processing method of same
CN103191163A (en) Skin wound repairing pharmaceutical composition
CN104208190A (en) Medicament for treating facial paralysis
CN1231920A (en) Formulation of medicine for treating scrofula, and its preparing process
CN104666615A (en) Nursing medicine for treating tremor

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20120627

WD01 Invention patent application deemed withdrawn after publication